Skip to main contentdfsdf

Clifford Meyers's List: surrogate endpt

Surrogate endpoints in drug approval process examined, found wanting - - Medical Economics | Practice Management

Mar 25, 10

medicaleconomics.modernmedicine.com/...522675
Access : Biomarkers and Surrogate End Points for Fit-for-Purpose Development and Regulatory Evaluation of New Drugs : Clinical Pharmacology & Therapeutics

Mar 25, 10

www.nature.com/...6100017a.html JA Wagner
Clinical Trials: Rising Costs Limit Innovation « Annals of Neurology

Mar 28, 10

annalsofneurology.wordpress.com/...-rising-costs-limit-innovation $26 000 for each patient in a phase III trial

1 - 3 of 3

20 items/page

List Comments (0)

List Info

Clifford Meyers

3 items | 2 visits

Updated on Mar 28, 10
Created on Mar 25, 10

Category: Not Categorized

URL: